SEARCH

SEARCH BY CITATION

References

  • 1
    Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8(Suppl 7): 193.
  • 2
    Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996; 87: 543552.
  • 3
    Lance JW & Goadsby PJ. Mechanisms and Management of Headache. Butterworth-Heinemann, Oxford, 1999: 79104.
  • 4
    Diener HC & Limmroth V. Acute management of migraine: triptans and beyond. Curr Opin Neurol 1999; 12: 261267.
  • 5
    Tfelt-Hansen P, Block G, Dahlof C, et al. Guidelines for controlled trials of drugs in migraine, 2nd edn. Cephalalgia. 2000; 20: 765786.DOI: 10.1046/j.1468-2982.2000.00117.x
  • 6
    Limmroth V, Kaube H, Diener HC. Management and Prevention of Migraine: a practical guide. In Migraine in Perspective, ed. Mallerkey, G. ADIS Books, Auckland, 1999: 1933.
  • 7
    Diener HC & Mathew NT. Drug-Induced-Headache. In Drug Treatment of Migraine and Other Headaches. Monographs in Clincal Neuroscience, Vol 17, ed. DienerHD. Karger, Basel, 2000: 347355.
  • 8
    Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS. Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic. Drugs 1984; 27: 644.
  • 9
    Tfelt-Hansen P. Trial design in migraine prophylaxis. In Drug Treatment of Migraine and Other Headaches. Monographs in Clincal Neuroscience, Vol 17, ed. Diener, HD. Karger, Basel, 2000: 244249.
  • 10
    Holdorff B, Sinn M, Roth G. Propranolol in der Migräneprophylaxe. Med Klin 1977; 72: 11151118.
  • 11
    Stensrud P & Sjaastad O. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Headache 1980; 20: 204207.
  • 12
    Al-Quassab HK & Findley LJ. Comparison of propranolol LA 80 mg and propranolol 160 mg in migraine prophylaxis. a placebo controlled study. Cephalalgia 1993; 13: 128131.
  • 13
    Steiner TJ, Joseph R, Hedman C, Rose FC. Metoprolol in the prophylaxis of migraine: parallel-groups comparison with placebo and dose-ranging follow-up. Headache 1988; 28: 1523.
  • 14
    Saper JR, Silberstein SD, Lake AE, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994; 34: 497502.
  • 15
    Kuritzki A, Zoldan Y, Melamed E. Selegeline, a MAO B inhibitor is not effective in the prophylaxis of migraine without aura – an open study. Headache 1992; 32: 416417.
  • 16
    Anthony M, Lance JW, Somerville B. A comparative trial of prindolol, clonidine and carbamazepine in the interval therapy of migraine. Med J Aust 1972; 1: 13431346.
  • 17
    Steiner TJ, Findley LJ, Yuen AW. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 1997; 17: 109112.
  • 18
    The Migraine-Nimodipine European Study Group (MINES). European multicenter trial of nimodipine in the prophylaxis of commen migraine (migraine without aura). Headache 1989; 29: 633638.
    Direct Link:
  • 19
    Albers GW, Simon LT, Hamik A, Peroutka SJ. Nifedipine versus propranolol for the initial prophylaxis of migraine. Headache 1989; 29: 214217.
  • 20
    Diener HC, Krupp P, Schmitt T, Steitz G, Milde K, Freytag S. Cyclandelate in the prophylaxis of migraine: a placebo-controlled study. Cephalalgia 2001; 21: 6670.
  • 21
    Solomon GD, Steel JG, Spaccavento LJ. Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study. JAMA 1983; 250: 25002502.
  • 22
    Markley HG, Cheronis JC, Piepho RW. Verapamil in prophylactic therapy of migraine. Neurology 1984; 34: 973976.
  • 23
    Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomized, placebo controlled crossover study. Br Med J 2001; 322: 1926.
  • 24
    Holroyd KA, Penzien DB, Rockicki LA, Cordingley GE. Flunarizine versus Propranolol. A meta-analysis of clinical trials. Headache 1992; 32: 256261.
  • 25
    Diener HC. Flunarizine for migraine prophylaxis. In Drug Treatment of Migraine and Other Headaches. Monographs in Clincal Neuroscience, Vol 17, ed. Diener HD. Karger, Basel, 2000: 269278.
  • 26
    Hering R & Kurzitzky A. Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 1992; 12: 8184.
  • 27
    Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology 1994; 44: 647651.
  • 28
    Mathew NT, Saper JR, Silberstein SD, et al. Migraine prophylaxis with divalproex. Arch Neurol 1995; 52: & 281286.
  • 29
    Baldretti A, Cortelli P, Proccaccianti G, Gamberini G, D'Alessandro Baruzzi A. Propanolol and acetylsalicylic acid in migraine prophylaxis. A double blind cross over study. Acta Neurol Scand 1983; 67: 181186.
  • 30
    Grotemeyer KH, Scharafinski HW, Schlake HP, Husstedt IW. Acetylsalicylic acid vs metoprolol in migraine prophylaxis — a double blind cross-over study. Headache 1990; 30: 639641.
  • 31
    Diener HC, Hartung E, Chrubasik J. Acetylsalicylic acid in migraine prophylaxis: a double blind study in comparison with metoprolol. Cephalalgia 1997; 17: 434.
  • 32
    Bellavance AJ & Meloche JP. A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis. Headache 1990; 30: 710715.
  • 33
    Kjaersgard Rasmussen MJ, Holt Larsen B, Borg L, Soelberg Sorensen P, Hansen PE. Tolfenamic acid versus propranolol in prophylactic treatment of migraine. Acta Neurol Scand 1994; 89: 446450.
  • 34
    Mylecharane EJ. 5-HT2 receptor antagonists and migraine therapy. J Neurol 1991; 238(Suppl 1): S45S52.
  • 35
    Silberstein SD. Methysergide. Cephalalgia 1998; 18: 421435.
  • 36
    Rabkin R, Stables DP, Levin NW, Suzman MM. Propanolol and prophylaxis of angina pectoris. Am J Cardiol 1966; 18: 370380.
  • 37
    Anderson KE & Vinge E. β-Adrenoreceptor blockers and calcium antagonists in the prophylaxis of migraine. Drugs 1990; 39: 355373.
  • 38
    Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991; 31: 333340.
  • 39
    Tfelt-Hansen P & Shanks RG. β-Adrenoreceptor blocking drugs. In The Headaches, eds OlesenJ, Tfelt-HansenP, WelchKMA. New York, Raven Press, 1993: 263372.
  • 40
    Limmroth V & Mummel P. Migraine Prophylaxis: Beta-blockers. In: DienerHD, ed. Drug Treatment of Migraine and Other Headaches. Monographs in Clincal Neuroscience, Vol 17. Karger, Basel, 2000: 256268.
  • 41
    Cruickshank JM & Prichard BNC. Beta-Blockers in Clinical Pratice. 2nd edn. Churchill Livingstone, Edinburgh, 1994.
  • 42
    Würz R, Reinhardt-Benmalek B, Grotemeyer K-H, Foh M. Bisoprolol and metoprolol in the prophylactic treatment of migraine with and without aura – a randomized double-blind cross-over multicenter study. Cephalalgia 1991; 11(Suppl 11): 152153.
  • 43
    Van De Ven LLM, Franke CL, Koehler PJ. Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study. Cephalalgia 1997; 17: 596599.
  • 44
    Forssman B, Lindblad CJ, Zbornikova V. Atenolol for migraine prophylaxis. Headache 1983; 23: 188190.
  • 45
    Johannsson V, Nilsson LR, Widelius T. Atenolol in migraine prophylaxis: a double-blind cross-over multicenter study. Headache 1987; 27: 372374.
  • 46
    Freitag FG & Diamond S. Nadolol and placebo comparison study in the prophylactic treatment of migraine. J Am Osteopath Assoc 1984; 84: 343347.
  • 47
    Ryan RE Sr, Ryan RE Jr, Sudilovski A. Nadolol: its use in the prophylactic treatment of migraine. Headache 1983; 23: 2631.
  • 48
    Ryan RE. Comparative study of nadolol and propanolol in prophylactic treatment of migraine. Am Heart J 1984; 108: 11561159.
  • 49
    Olerud B, Gustavsson CL, Furberg B. Nadolol and propanolol in migraine management. Headache 1986; 26: 490493.
  • 50
    Sudlikovski A, Elkind AH, Ryan RE Sr, Saper JR, Stern MA, Meyer JH. Comparative efficacy of nadolol and propanolol in the management of migraine. Headache 1987; 27: 421426.
  • 51
    Tfelt-Hansen P, Standnes B, Kangasniemi P, Hakkarainen H, Oleson J. Timolol vs. propranolol vs. placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand 1984; 69: 18.
  • 52
    Stellar S, Ahrens SP, Meibohm AR, Reines SA. Migraine prevention with timolol. JAMA 1984; 252: 25762257.
  • 53
    Nanda RN, Johnson RH, Gray J, Keogh HJ, Melville ID. A double blind trial of acebutolol for migraine prophylaxis. Headache 1978; 18: 2022.
  • 54
    Ekbom K. Alprenolol for migraine prophylaxis. Headache 1975; 15: 129132.
  • 55
    Ekbom K & Zetterman M. Oxprenolol in the treatment of migraine. Acta Neurol Scand 1977; 56: 181184.
  • 56
    Sjastaad O & Stenrud P. Clinical trial of a beta-receptor blocking agent (LB46) in migraine prophylaxis. Acta Neurol Scand 1972; 48: 124128.
  • 57
    Ekbom K & Lundberg PO. Clinical trial of LB-46 (d, 1–4 (2-hydroxy-3-isopropylaminopropoxy) indol), an adrenergic betareceptor blocking agent in migraine prophylaxis. Headache 1972; 12: 1517.
  • 58
    Castro ME, Harrison PJ, Pazos A, Sharp T. Affinity of & (+/−)-pindolol, (−)-penbutolol, and (−)-tertatolol for pre- and post-synaptic serotonin 5-HT (1A) receptors in human and rat brain. J Neurochem 2000; 75: 755762.DOI: 10.1046/j.1471-4159.2000.0750755.x
  • 59
    Voigt MM, Laurie DJ, Seeburg PH, Bach A. Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor. EMBO J 1991; 10: 40174023.
  • 60
    Zgombick JM, Bard JA, Kucharewicz SA, Urquhart DA, Weinshank RL, Branchek TA. Molecular cloning and pharmacological characterization of guinea pig 5-HT1B and 5-HT1D receptors. Neuropharmacology 1997; 36: 513524.DOI: 10.1016/s0028-3908(97)00023-3
  • 61
    Grotemeyer KH, Schlake HP, Husstedt IW. Migräneprophylaxe mit Metoprolol und Flunarizin. – Eine doppelblind-crossover Studie. Nervenarzt 1988; 59: 549552.
  • 62
    Ludin HP. Flunarizine and propanolol in the treatment of migraine. Headache 1989; 29: 218223.
  • 63
    Shimell CJ, Fritz VU, Levien SL. A comparative trial of flunarizine and propranolol in the prevention of migraine. S Afr Med J 1990; 77: 7577.
  • 64
    Lutschg J & Vassella F. The treatment of juvenile migraine using flunarizine or propranolol. Schweiz Med Wochenschr 1990; 120: 17311736.
  • 65
    Sorensen PS, Larsen BH, Rasmussen MJ, et al. Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability. Headache 1991; 31: 650657.
  • 66
    Gawel MJ, Kreeft J, Nelson RF, Simard D, Arnott WS. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine. Can J Neurol Sci 1992; 19: 340345.
  • 67
    Verspeelt J, Locht P, Amery WK. Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine. Cephalalgia 1996; 16: 328336.
  • 68
    Bordini CA, Arruda MA, Ciciarelli MC, Speciali JG. Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial. Arq Neuropsiquiatr 1997; 55: 536541.
  • 69
    Kozubski W & Prusinski A. Sodium valproate versus propranolol in the prophylactic treatment of migraine. Neurol Neurochir Pol 1995; 29: 937947.
  • 70
    Kaniecki RG. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. Arch Neurol 1997; 54: 11411145.
  • 71
    Buring JE, Peto R, Hennekens CH. Low-dose aspirin for migraine prophylaxis. JAMA 1990; 264: 1711.